 RESEARCH TRIANGLE PARK, N.C., May 07, 2021 GLOBE NEWSWIRE -- G1 Therapeutics, Inc. Nasdaq: GTHX, a commercial-stage oncology company, today announced the grant of inducement stock options exercisable for an aggregate of 40,000 shares of G1s common stock to five employees under the G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan the Inducement Plan. The stock options were granted as an inducement material to the new employees becoming an employee of G1 in accordance with Nasdaq Listing Rule 5635c4. 